IOSP 10-K & 10-Q changes, risk factors and insider trading
Innospec Inc. · Nasdaq · Chemicals & Allied Products · CIK 1054905 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Largest changes
The sales of our AvGas product line for use in aviation gasoline are recorded within our Fuel Specialties business. The piston aviation industry has been, and is currently, researching a safe replacement fuel to replace leaded fuel. The U.S. Federal Aviation Administration (“FAA”) program (Piston Aviation Fuels Initiative) has been established to identify a replacement fuel, and candidate fuels are undergoing testing. In 2022, various general aviation industry groups in conjunction with the US EPA and FAA created a new team named Eliminate Aviation Gasoline Lead Emissions (“EAGLE”). This is a government-industry partnership that also encompasses fuel producers and distributors, airport operators, communities that support general aviation airports, and environmental experts. The most significant announcement impacting the Company is the stated aim of EAGLE to eliminate lead emissions from general aviation in the U.S. by the end ofsee in full comparison2030.2030TherewithareAlaskaalsohavingregulatoryaactionsderogationunderwayoutforto end 2032. Regulatory action in theE.U., which are proposing a banEU on theproductionprohibition of TEL use by EU based leadedfuelavgas blenders under the EU REACH Regulations has resulted in three users successfully applying forthe aviation industry earlier than the FAA timetable, unless an authorization under E.U.EU REACHisAuthorizationgrantedpermittingtocontinuedtheTELfueluseproducer.until end of April 2032.
“In 2021, the Organization for Economic Cooperation and Development (“OECD”) released Pillar Two Global Anti-Base Erosion model rules (“Pillar Two Rules”), designed to ensure large corporations are taxed at a minimum rate of 15% in all countries of operation. Although the U.S. has not enacted legislation implementing Pillar Two Rules, other countries where Innospec does business, including the U.K., have enacted legislation implementing Pillar Two Rules, which came into effect from January 1, 2024. …”see in full comparison
“Diverse chemical regulatory processes in different countries around the world might create complexity and additional cost. U.K. REACH, which was precipitated by the U.K.’s exit from the E.U., is one such example.”see in full comparison
We are currently in the process of developing and implementing a new, company-wide, information system platform. The new platform provider is well established in the market. The implementation is a phased, risk-managed, site deployment following a multistage user acceptance program with the existing platforms providing a fallback position.see in full comparisonWeIn 2025 and 2024 we have implemented the new platform for a number of our sites acrossEMEAEMEA, ASPAC andASPAC inthethird quarter of 2024.Americas. In connection with this implementation, the Company has updated, and continues to update, its internal controls over financial reporting, as necessary, to accommodate modifications to its business processes and accounting procedures.
Full comparison: every changed paragraph (8)
The level of inflation and energy costs may result in an adverse impact toon the group’s results from employee wages and other costs of operations of our manufacturing sites.
We are currently in the process of developing and implementing a new, company-wide, information system platform. The new platform provider is well established in the market. The implementation is a phased, risk-managed, site deployment following a multistage user acceptance program with the existing platforms providing a fallback position. WeIn 2025 and 2024 we have implemented the new platform for a number of our sites across EMEAEMEA, ASPAC and ASPAC in the third quarter of 2024.Americas. In connection with this implementation, the Company has updated, and continues to update, its internal controls over financial reporting, as necessary, to accommodate modifications to its business processes and accounting procedures.
Furthermore, the potential for problems with any of our integrated and stand-alone information technology systems, including communication technologies, could negatively impact our customers, suppliers and employees. As a result, there could be a consequential adverse impact on our results of operationsoperations, financial condition and financialcash condition.flows.
The sales of our AvGas product line for use in aviation gasoline are recorded within our Fuel Specialties business. The piston aviation industry has been, and is currently, researching a safe replacement fuel to replace leaded fuel. The U.S. Federal Aviation Administration (“FAA”) program (Piston Aviation Fuels Initiative) has been established to identify a replacement fuel, and candidate fuels are undergoing testing. In 2022, various general aviation industry groups in conjunction with the US EPA and FAA created a new team named Eliminate Aviation Gasoline Lead Emissions (“EAGLE”). This is a government-industry partnership that also encompasses fuel producers and distributors, airport operators, communities that support general aviation airports, and environmental experts. The most significant announcement impacting the Company is the stated aim of EAGLE to eliminate lead emissions from general aviation in the U.S. by the end of 2030.2030 Therewith areAlaska alsohaving regulatorya actionsderogation underwayout forto end 2032. Regulatory action in the E.U., which are proposing a banEU on the productionprohibition of TEL use by EU based leaded fuelavgas blenders under the EU REACH Regulations has resulted in three users successfully applying for the aviation industry earlier than the FAA timetable, unless an authorization under E.U.EU REACH isAuthorization grantedpermitting tocontinued theTEL fueluse producer.until end of April 2032.
In 2021, the Organization for Economic Cooperation and Development (“OECD”) released Pillar Two Global Anti-Base Erosion model rules (“Pillar Two Rules”), designed to ensure large corporations are taxed at a minimum rate of 15% in all countries of operation. Although the U.S. has not enacted legislation implementing Pillar Two Rules, other countries where Innospec does business, including the U.K., have enacted legislation implementing Pillar Two Rules, which came into effect from January 1, 2024. We have evaluated the Pillar Two Rules and their impact on the current and future periods, and we have determined that the Pillar Two Rules do not have a material impact on the Company’s effective tax rate in the current period, and we do not expect the rules to have a material impact on the Company’s effective tax rate in future periods.
Diverse chemical regulatory processes in different countries around the world might create complexity and additional cost. U.K. REACH, which was precipitated by the U.K.’s exit from the E.U., is one such example.
The outcome of new or potential legislation or regulation in the U.S. and other jurisdictions in which we operate may result in new or additional requirements, additional charges to fund energy efficiency activities, fees or restrictions on certain activities. Compliance with these initiatives may also result in additional costs to us, including, among other things, increased production costs, additional taxes, reduced emission allowances or additional restrictions on production or operations. Any climate change regulations enacted in the future could also negatively impact our ability to compete with companies situated in areas not subject to such limitations. Even without such regulation, increased public awareness and adverse publicity about potential impacts on climate change emanating from us or our industry could harm us. We may not be able to recover the cost of compliance with new or more stringent laws and regulations, which could adversely affect our business and negatively impact our growth. Furthermore, the potential impacts of climate change and related regulation on our customers are highly uncertain and may adversely affect us.our results of operations, financial position and cash flows.
Approximately 45%37% of our common stock is held by fourthree stockholders. A decision by any of these, or other substantial, stockholders to sell all or a significant part of its holding, or a sudden or unexpected disposition of our stock, could result in a significant decline in our stock price. This could in turn adversely impact our ability to access equity markets, which could adversely impact our results of operations, financial position and cash flows.
Management's Discussion & Analysis (MD&A)
New heading “Other intangible assets and property, plant and equipment (net of amortization and depreciation, respectively)”
New heading “Results of Operations – Fiscal 2025 compared to Fiscal 2024:”
Removed heading “Results of Operations – Fiscal 2023 compared to Fiscal 2022:”
Largest changes
“Other intangible assets and property, plant and equipment (net of amortization and depreciation, respectively)”see in full comparison
“If a quantitative test is required, undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the assets and, if such cash flows are lower, an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the assets. Fair values are determined using post-tax cash flows discounted at the Company’s weighted average cost of capital. …”see in full comparison
“We also recognize tax benefits to the extent that it is more likely than not that our positions will be sustained, based on technical merits of the position, when challenged by the taxing authorities. To the extent that we prevail in matters for which liabilities have been established or are required to pay amounts in excess of the liabilities recorded in our financial statements, our effective tax rate in a given period may be materially affected. An unfavorable tax settlement may require cash payments and result in an increase in our effective tax rate in the year of resolution. …”see in full comparison
“We generated cash from operating activities of $184.5 million in 2024 compared to $207.3 million in 2023. The decrease in cash is primarily related to our increased working capital, being partly offset by the improvements to our earnings before depreciation, amortization and excluding the one off non-cash impact relating to the U.K. defined benefit pension scheme buy-out.”see in full comparison
Full comparison: every changed paragraph (78)
In 20242025, Innospec achieveddelivered anothera goodmixed set of results.results Strengthwith continued strong operating income growth and margin expansion in Fuel Specialties offsetting lower results in Performance Chemicals and Fuel Specialties offset lower results in Oilfield Services.
In Performance Chemicals, full year revenues were up 4 percent on the prior year; however, margins declined on higher costs, price management and weaker product mix. While these results were below our expectations, margin actions began to take effect in the third quarter, and together with lower overheads drove sequential improvement in the fourth quarter. Delivering sustainable margin improvement remains the primary focus of the business team. We continue to execute on a range of price/cost management, productivity and new product commercialization actions over the short-to-medium term. New products include the continued expansion of our industry-leading sulfate and 1,4-dioxane free personal and home care portfolio and growth in our technologies for agriculture, mining, construction and other diversified industrial markets. We expect these combined efforts to drive further growth in 2026.
In Performance Chemicals, full year revenues were up 16 percent and operating income increased by 52 percent. We have a balanced pipeline of growth opportunities across our global personal care, home care, agriculture, construction and other industrial markets. In addition, the integration and performance of our recent QGP acquisition in Brazil is proceeding to plan and is supporting not only Performance Chemicals but also Fuel Specialties growth opportunities in the region. Moving into 2025, we continue to target operating income and margin improvement to levels consistent with the full year 2022.
In Fuel Specialties, full year revenues were upunchanged 1on percentthe prior year and operating income increased 1812 percent.percent Operatingbenefiting marginfrom improveda stronger sales mix and disciplined pricing. The business has continued to justdeliver belowconsistently ourstrong targetresults and has a diverse pipeline of 19fuel toand 21non-fuel percent.growth Weopportunities remainacross focusedall on further margin improvement in parallel with topline growth.regions. With our industry-leading innovation and customer service capabilities, we are well positioned to continue advancing our global customers’ initiatives. Our technology will continue to focus on cleaner fuels, lowering emissions and improving efficiency in traditional, renewable and non-fuel applications.
In Oilfield Services, full year revenues were down 2919 percent fromon lastthe yearprior year, and operating income decreased 5140 percent ondriven by no recovery in our Latin American business and lower Latinthan Americaexpected productionMiddle activity. Excluding this Latin America activity, our core business salesEast and US completion activity in the second half of 2025. We remain focused on delivering operating income grewgrowth yearin over2026 year.as OurMiddle expectationEast foractivity 2025returns, issales thatfrom weour willrecent seeDRA furtherexpansion sequentialtake effect, and our focus on margin improvement in the core Oilfield business including U.S. completions and production, DRA and the Middle East.continues. We currently do not expect the Latin America production activity to resume in the near term.2026.
For the full year, cash from operations after capital expenditures remained strong at $63.9 million. As of December 31, 2025, Innospec had $292.5 million in cash and cash equivalents and no debt. Full year dividend payments increased by 10 percent over the prior year to $1.71 per share and we bought back 264 thousand shares at a cost of $23.9 million. We continue to have significant balance sheet flexibility for M&A, dividend growth, organic investment and buybacks.
We are subject to environmental laws in the countries in which we conduct business. Ellesmere Port in the U.K. is our principal site giving rise to asset retirement obligations, associatedprimarily withconnected to the production of TEL.tetra ethyl lead. There are also asset retirement obligations and environmental remediation liabilities on a much smaller scale in respect of other manufacturing sites. At Ellesmere Port there is a continuing asset retirement program related to certain manufacturing units that have been closed.
Plant closure provisions at December 31, 20242025 amounted to $60.3$65.1 million and relate principally to asset retirement obligations at our Ellesmere Port site in the U.K.. We recognize environmental remediation liabilities when they are probable and costs can be reasonably estimated, and asset retirement obligations when there is a legal requirement, including those arising from a Company promise, and the costs can be reasonably estimated. The Company must anticipatemake significant judgments when anticipating the program of work required and the associated future expected costs, and comply with environmental legislation in the countries in which it operates or has operated in. We develop these assumptions utilizing the latest information available together with recent costs. While we believe our assumptions for plant closure provisions are reasonable, they are subjective good faith estimates and it is possible that variations in any of the assumptions will result in materially different calculations to the liabilities we have reported.
Income Taxes
We are subject to income and other taxes in the U.S., the U.K., and a number of other jurisdictions. Tax laws are dynamic and subject to change as new laws are passed and new interpretations of the law are issued or applied.
The calculation of our tax liabilities involves evaluating uncertainties in the application of accounting principles and complex tax regulations. We recognize liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes will be required. If we ultimately determine that payment of these amounts is unnecessary, we reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary.
We also recognize tax benefits to the extent that it is more likely than not that our positions will be sustained, based on technical merits of the position, when challenged by the taxing authorities. To the extent that we prevail in matters for which liabilities have been established or are required to pay amounts in excess of the liabilities recorded in our financial statements, our effective tax rate in a given period may be materially affected. An unfavorable tax settlement may require cash payments and result in an increase in our effective tax rate in the year of resolution. We report interest and penalties related to uncertain tax positions as income taxes. For additional information regarding uncertain income tax positions, see Note 11 of the Notes to the Consolidated Financial Statements.
Other intangible assets and property, plant and equipment (net of amortization and depreciation, respectively)
Other intangible assets and property, plant and equipment are tested for impairment at the lowest possible level for which cash flows can be sufficiently distinguished, operationally and for financial reporting purposes.
To test for impairment the Company reviews whether there have been any changes or indicators of potential impairment. Factors utilized in the qualitative assessment process include macroeconomic conditions; industry and market considerations; cost factors; overall financial performance; and Company specific events.
If a quantitative test is required, undiscounted future cash flows expected to result from the asset groups are compared with the carrying value of the assets and, if such cash flows are lower, an impairment loss may be recognized. The amount of the impairment loss is the difference between the fair value and the carrying value of the assets. Fair values are determined using post-tax cash flows discounted at the Company’s weighted average cost of capital. These fair value techniques require management judgment and estimates including revenue growth rates, projected operating margins, changes in working capital and discount rates. We would develop these assumptions by considering recent financial performance and trends and industry growth estimates. While we believe our assumptions for impairment assessments are reasonable, they are subjective judgments, and it is possible that variations in any of the assumptions will result in materially different calculations of any potential impairment charges.
For the quarter ended September 30, 2025, we recorded impairment charges relating to our Performance Chemicals and Oilfield Services segments. See Note 6 and Note 9 of the Notes to the Consolidated Financial Statements for additional information.
At December 31, 2025 we had $67.7 million of intangible assets, included in Corporate costs and our Performance Chemicals segment, and we had $286.1 million of net property, plant and equipment for the Group in total. Our review at December 31, 2025 highlighted no indicators of potential impairment and the amortization and depreciation periods remain appropriate.
Results of Operations – Fiscal 2025 compared to Fiscal 2024:
Higher sales volumes for the Americas were driven by increased demand for our personal care products, being offset by an adverse price and product mix due to pricing erosion and higher demand for our lower priced products. The volume decline in EMEA was offset by a favorable price and product mix, primarily driven by increased demand for our higher priced products. ASPAC volumes were higher driven by increased demand for our personal care products, being partly offset by an adverse price and product mix due to higher demand for lower priced personal care products. EMEA and ASPAC benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year decrease of 4.8 percentage points was primarily due to pricing erosion and higher demand for our lower margin products.
Operating expenses: decreased by $4.5 million year over year, primarily due to lower provisions for performance-related remuneration accruals, together with lower charges for doubtful debts.
Sales volumes in the Americas have remained constant year over year, combined with an adverse price and product mix due to a weaker sales mix. Sales volumes in EMEA have increased year over year due to increased demand from customers. Sales volumes in ASPAC have decreased year over year due to decreased demand from customers, being partly offset by a favorable price and product mix due to an improved sales mix and disciplined pricing. AvGas volumes were higher than the prior year due to variations in the demand from customers, being offset by an adverse price and product mix due to an adverse customer mix. EMEA and ASPAC benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year increase of 1.8 percentage points was driven by increased sales of higher margin products, together with disciplined pricing and reduced inflationary pressures.
Operating expenses: the year over year decrease of $2.9 million was due to lower provisions for performance-related remuneration accruals, lower research and development expenditure and favorable movements for doubtful debt provisions.
Net sales: have decreased year over year by $95.5 million, or 19 percent, with the majority of our customer activity concentrated in the Americas region. Sales volumes in the current year were adversely impacted by the absence of production chemical activity in Mexico.
Gross margin: the year over year decrease of 1.6 percentage points was due to an unfavorable sales mix as our customer demand has weakened.
Operating expenses: the year over year decrease of $20.9 million was due to lower customer service costs and commissions related to the reduced demand from certain customers, together with lower provisions for performance-related remuneration accruals.
Corporate costs: the year over year increase of $2.6 million was due to the prior year including the recovery of $8.4 million of historical pension costs, increased provisions for asset retirement obligations in relation to our legacy operations, the additional investment in our IT infrastructure and the amortization of the group's new ERP system, being partly offset by lower provisions for performance-related remuneration accruals.
Adjustment to fair value of contingent consideration: the credit in the current year of $15.9 million compares to an expense of $3.4 million in the prior year. The amounts in both years relate to the acquisition of QGP Química Geral (“QGP”) within our Performance Chemicals segment. See Note 14 of the Notes to the Consolidated Financial Statements for additional information.
Restructuring charge: the charge in the current year is $0.9 million compared to no charge in the prior year. The charge relates to our operations in South America within our Performance Chemicals segment.
Impairment of property, plant and equipment: the charge in the current year is $22.9 million compared to no charge in the prior year. The charge relates to our Oilfield Services segment. See Note 6 of the Notes to the Consolidated Financial Statements for additional information.
Impairment of intangible assets: the charge in the current year is $19.1 million compared to no charge in the prior year. The charge relates to our Performance Chemicals and Oilfield Services segments. See Note 9 of the Notes to the Consolidated Financial Statements for additional information.
Other net income/(expense): for 2025 and 2024, includes the following:
Interest income/(expense), net: was $9.2 million of income in 2025 compared to $9.3 million of income in 2024, driven by the interest income being earned from our cash balances.
Income taxes: The effective tax rate was 15.6% and 13.6% in 2025 and 2024, respectively. The adjusted effective tax rate, as calculated by adjusting income before taxes and by adjusting income taxes for the items set out in the following table, was 24.1% in 2025 compared with 26.4% in 2024. The Company believes this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.
The adjusted effective tax rate is higher in 2025 than the GAAP effective tax rate, primarily due to the recognition of a deferred tax benefit in relation to internal reorganizations being eliminated in determining the adjusted effective tax rate.
The adjusted effective tax rate was higher in 2024 than the GAAP effective tax rate, primarily due to the recognition of previously unrecognized tax benefits being eliminated in determining the adjusted effective tax rate. This item arose due to the lapse of the statute of limitations associated with the unrecognized tax benefit in the final quarter of 2024.
For additional information on items which impact both the GAAP effective tax rate and the adjusted effective tax rate see Note 11 of the Notes to the Consolidated Financial Statements.
Higher sales volumes for all our regions were driven by increased demand for our personal care and home care products resulting from higher consumer demand, in particular for lower priced higher volume products. The acquisition of the QGP businessin December 2023 has also delivered increased volumes year over year. All our regions recorded an adverse price and product mix due to lower selling prices, driven by lower raw material costs, together with the greater demand from consumers for lower priced products.
Operating expenses: the year over year increase of $4.9 million iswas due to higher research and development expenditure and higher performance-related remuneration accruals, being partly offset by lower provisions for doubtful debts.
Income taxes: The effective tax rate was 13.6% and 20.2% in 2024 and 2023, respectively. The adjusted effective tax rate, onceas adjustedcalculated by adjusting income before taxes and by adjusting income taxes for the items set out in the following table, was 26.4% in 2024 compared with 23.0% in 2023. The Company believes this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.
The adjusted effective tax rate iswas higher in 2024 than the GAAP effective tax rate, primarily due to the current year recognition of previously unrecognized tax benefits being eliminated in determining the adjusted effective tax rate. This item arose due to the lapse of the statute of limitations associated with the unrecognized tax benefit in the final quarter of 2024.
Results of Operations – Fiscal 2023 compared to Fiscal 2022:
Lower sales volumes for all of our regions were primarily driven by reduced demand for our personal care products resulting from cautious consumer sentiment, together with the impact of destocking by our customers. The Americas and EMEA were impacted by an adverse price and product mix due to a higher proportion of lower priced products being sold. ASPAC benefited from a favorable price and product mix due to a higher proportion of higher priced products being sold.
Gross margin: the year over year decrease of 4.6 percentage points was due to an adverse sales mix from reduced sales of higher margin products and the adverse impact of reduced manufacturing efficiency resulting from lower production volumes.
Operating expenses: decreased $3.6 million year over year, due to lower selling expenses including commissions, lower performance-related remuneration accruals and lower acquired intangibles amortization following the end of the expected life of the assets.
Sales volumes in all of our regions have decreased year over year, primarily due to a reduction in the sales of lower margin higher volume products. Price and product mix was favorable in all our regions due to an increased proportion of higher margin products being sold. AvGas volumes were lower than the prior year due to variations in the demand from customers, together with an adverse price and product mix due to a higher proportion of sales to lower margin customers.
Gross margin: the year over year increase of 0.5 percentage points was primarily due to a favorable sales mix from increased sales of higher margin products, being partly offset by the impact of the Brazil inventory misappropriation and the ending of that trading relationship.
Operating expenses: the year over year increase of $5.2 million includes increased research and development expenditure and higher provisions for doubtful debts which are primarily related to the ending of the Brazilian trading relationship, being partly offset by lower performance-related remuneration accruals.
Net sales: have increased year over year by $97.5 million, or 16%, with the majority of our customer activity concentrated in the Americas region. We believe that customer demand remains strong despite operating income growth moderating, as expected, through the second half of the 2023.
Gross margin: the year over year increase of 2.9 percentage points was due to a favorable sales mix and the benefit of improved pricing.
Operating expenses: the year over year increase of $18.7 million was driven by higher customer service costs which are necessary to support the increase in demand with certain customers, together with higher provisions for doubtful debts, while being partly offset by lower performance-related remuneration accruals.
Corporate costs: the year over year increase of $9.8 million was primarily due to acquisition related costs, additional environmental remediation provisions, increased spending on our information technology infrastructure and some legal costs related to the Brazil inventory misappropriation, being partly offset by lower performance-related remuneration accruals.
Other net income/(expense): for 2023 and 2022, includes the following:
Interest income/(expense), net: was income of $2.3 million in 2023 primarily due to the interest earned on the Company's cash balances, compared to a $1.1 million expense in 2022 primarily due to the commitment fee which the Company paid to retain its revolving credit facility for the term of the agreement.
Income taxes: The effective tax rate was 20.2% and 28.0% in 2023 and 2022, respectively. The adjusted effective tax rate, once adjusted for the items set out in the following table, was 23.0% in 2023 compared with 27.0% in 2022. The Company believes that this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.
The adjusted effective tax rate is higher in 2023 than the GAAP effective tax rate, primarily due to elimination of the impact of other discrete items. This mainly represents the benefit arising from adjustments to the tax charge for previous years arising from return to provision adjustments in relation to the federal and state tax returns filed in the U.S. during 2023.
Our adjusted effective tax rate was lower in 2022 than the GAAP effective tax rate primarily due to the elimination of stock compensation activity.
Foreign income inclusions arise each year from certain types of income earned overseas being taxable under U.S. regulations. Foreign tax credits can fully or partially offset these incremental U.S. taxes from foreign income inclusions. The utilization of foreign tax credits varies year on year as this is dependent on a number of variable factors which are difficult to predict and may prevent offset. The GAAP effective tax rate and the adjusted effective tax rate in both 2023 and 2022 have been negatively impacted by these items.
What changed in the latest 10-Q
Risk Factors
Information regarding risk factors that could have a material impact on our results of operations or financial condition are described under “Risk Factors” in Item 1A of Part I of our 2025 Form 10-K. In management’s view, there have been no material changes in the risk factors facing the Company as disclosed in those SEC filings.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“Interest income/(expense), net: in the three months ended June 30, 2026 was $0.8 million of income compared to $2.7 million of income in the three months ended June 30, 2025, driven by lower interest rates and lower cash balances in the current year.”see in full comparison
“Interest income/(expense), net: in the six months ended June 30, 2026 was $1.6 million of income compared to $5.1 million of income in the six months ended June 30, 2025, driven by lower interest rates and lower cash balances in the current year.”see in full comparison
“Income taxes: the effective tax rate was 23.9% and 25.8% in the first six months of 2026 and 2025, respectively. The adjusted effective tax rate, once adjusted for the items set out in the following table, was 23.0% in 2026 compared with 23.7% in 2025. The 0.7% decrease in the adjusted effective rate was primarily due to the fact that a higher proportion of the Company’s profits are being generated in lower tax jurisdictions. …”see in full comparison
“The Americas volumes were lower due to some supply constraints and reduced demand for our personal care products, partly offset by a favorable price and product mix due to continuing pricing improvements. Volumes in EMEA were higher, being partly offset by an adverse price and product mix driven by higher demand for our lower priced products. ASPAC volumes were lower driven by some supply constraints and decreased demand for certain products, being partly offset by a favorable price and product mix. EMEA and ASPAC benefited from favorable foreign currency exchange rate movements.”see in full comparison
“Sales volumes in all our regions increased year over year due to increased demand from customers. The Americas and ASPAC were impacted by an adverse price and product mix due to higher sales of lower priced products. EMEA benefited from a favorable price and product mix due to higher sales of higher priced products. AvGas volumes were lower than the prior year due to variations in the demand from customers, being partly offset by a favorable customer mix. All our regions benefited from favorable foreign currency exchange rate movements.”see in full comparison
“Adjustment to fair value of contingent consideration: is a credit in the current year of $4.6 million compared to an expense in the prior year of $1.5 million. The adjustment relates to the acquisition of QGP within our Performance Chemicals segment. The credit in the current year relates to a reduction in the expected payable, together with the lower accretion charge calculated on the lower expected payable. See Note 10 of the Notes to the Condensed Consolidated Financial Statements for additional information.”see in full comparison
Full comparison: every changed paragraph (44)
Three Months Ended MarchJune 31,30, 2026
The following table shows the changes in sales, gross profit and operating expenses by reporting segment for the three months ended MarchJune 31,30, 2026, and the three months ended MarchJune 31,30, 2025:
Volumes for theThe Americas volumes were lower due to some supply constraints and reduced demand for our personal care products, partly offset by a favorable price and product mix due to pricing improvements. Volumes in EMEA were lower,higher due to increased demand for our personal care products, combined with ana adversefavorable price and product mixmix, driven by higher demand for lowerour higher priced products. ASPAC volumes were lower drivendue byto some supply constraints and decreased demand for our personal carecertain products, slightlybeing offset by a favorable price and product mix.mix, driven by higher demand for our higher priced products. EMEA and ASPAC benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year decrease of 4.20.2 percentage points was primarily due to an adverse sales mix, together with the negative manufacturing variances in North America due to lower production volumes in North America, as we continue to advance our plant repairs, process improvements and upgrades following severe weather conditions atin the start of thefirst quarter.
Operating expenses: the year over year increase of $2.2$0.4 million year over year was primarily due to adverse movements to thehigher provisions for doubtfulperformance-related debtsremuneration driven by our aged debtor accounting policy, together with increased research and development expenses.accruals.
Sales volumes in allthe our regionsAmericas increased year over year due to increased demand from customers.customers, Allbeing ourpartly regions were impactedoffset by an adverse price and product mixmix. Sales volumes in EMEA increased year over year due to higherincreased salesdemand offrom lowercustomers, pricedcombining products.with a favorable price and product mix. Sales volumes in ASPAC decreased year over year due to decreased demand from customers, being offset by a favorable price and product mix. AvGas volumes were lower than the prior year due to variations in the demand from customers, beingcombined offsetwith byan a favorableadverse customer mix. EMEAAll andour ASPACregions benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year decrease of 0.31.5 percentage points was due to an adverse sales mix in the Americas from increased sales of lower margin products, being partly offset by sales in EMEA of higher margin products.
Operating expenses: the year over year increase of $2.6$4.2 million was primarily due to adverse movements to the provisions for doubtful debts driven by our aged debtor accounting policy,debts, together with increased administrativeemployee-related expenses.costs, including higher provisions for performance-related remuneration accruals.
Net sales: have increased year over year by $0.1$14.6 million.million, Sales in the Americas were higher year over year, being partly outweigheddriven by lowerour salesDRA inplant EMEA.expansion and associated demand. The majority of ourthe customersegment's activitysales isare concentrated in the Americas region.
Operating expenses: the year over year increase of $0.3$5.0 million was primarily due to adverse movements to the provisions for doubtful debts, together with increased operating expenses and increased employee-related costs, including higher sellingprovisions expenses.for performance-related remuneration accruals.
Corporate costs: the year over year increase of $4.6$0.7 million was primarily due to higher legal and compliance expenses, together with higher information technology costs including additional amortization for our new ERP system, and higher provisions for performance-related remuneration accruals, being partly offset by lower legacy costs of closed operations,operations anand adversea favorable revaluation for theour U.K. emissions trading scheme carbon credits, higher legal and compliance expenses and additional amortization for the new ERP system.credits.
Adjustment to fair value of contingent consideration: is aan creditexpense in the current year of $4.7$0.1 million compared to an expense in the prior year of $0.7$0.8 million. The adjustment relates to the acquisition of QGP within our Performance Chemicals segment. The year over year decrease relates to reduced accretion, due to the reduction in the overall expected payable compared to the prior year. See Note 10 of the Notes to the Condensed Consolidated Financial Statements for additional information.
Other net income/(expense): for the three months ended March 31, 2026 and 2025, included the following:
InterestOther net income/(expense),: net:for the three months ended June 30, 2026 was $1.1 million income compared to a $4.7 million expense in the three months ended MarchJune 31, 2026 was $0.8 million of income compared to $2.4 million of income in the three months ended March 31,30, 2025, primarily driven by lowerthe interestrevaluation ratesof foreign currency forward contracts, and lowerthe cashforeign currency translation of non-USD balances in the current year.group.
Interest income/(expense), net: in the three months ended June 30, 2026 was $0.8 million of income compared to $2.7 million of income in the three months ended June 30, 2025, driven by lower interest rates and lower cash balances in the current year.
Income taxes: the effective tax rate was 22.8%25.0% and 25.7%26.0% in the firstsecond quarter of 2026 and 2025, respectively. The adjusted effective tax rate, once adjusted for the items set out in the following table, was 22.9%23.1% in 2026 compared with 24.0%23.3% in 2025. The 1.1%0.2% decrease in the adjusted effective rate was primarily due to the fact that a higher proportion of the Company’s profits are being generated in lower tax jurisdictions. The Company believes that this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.
The following table shows a reconciliation of the GAAP effective tax charge to the adjusted effective tax charge:
Six months ended June 30, 2026
The following table shows the changes in sales, gross profit and operating expenses by reporting segment for the six months ended June 30, 2026, and the six months ended June 30, 2025:
Net sales: the table below details the components which comprise the year over year change in net sales spread across the markets in which we operate:
The Americas volumes were lower due to some supply constraints and reduced demand for our personal care products, partly offset by a favorable price and product mix due to continuing pricing improvements. Volumes in EMEA were higher, being partly offset by an adverse price and product mix driven by higher demand for our lower priced products. ASPAC volumes were lower driven by some supply constraints and decreased demand for certain products, being partly offset by a favorable price and product mix. EMEA and ASPAC benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year decrease of 2.1 percentage points was primarily due to an adverse sales mix, together with the negative manufacturing variances in North America due to lower production volumes following severe weather conditions in the first quarter.
Operating expenses: the year over year increase of $2.6 million was primarily due to adverse movements to the provisions for doubtful debts, together with increased research and development expenses and higher provisions for performance-related remuneration accruals, being partly offset by reductions for other expenses.
Net sales: the table below details the components which comprise the year over year change in net sales spread across the markets in which we operate:
Sales volumes in all our regions increased year over year due to increased demand from customers. The Americas and ASPAC were impacted by an adverse price and product mix due to higher sales of lower priced products. EMEA benefited from a favorable price and product mix due to higher sales of higher priced products. AvGas volumes were lower than the prior year due to variations in the demand from customers, being partly offset by a favorable customer mix. All our regions benefited from favorable foreign currency exchange rate movements.
Gross margin: the year over year decrease of 0.9 percentage points was due to an adverse sales mix in the Americas from increased sales of lower margin products, being partly offset by sales in EMEA of higher margin products.
Operating expenses: the year over year increase of $6.8 million was primarily due to adverse movements to the provisions for doubtful debts, together with increased operating expenses and increased employee-related costs, including higher provisions for performance-related remuneration accruals.
Net sales: have increased year over year by $14.7 million, driven by our DRA plant expansion and associated demand. The majority of the segment's sales are concentrated in the Americas region.
Gross margin: the year over year increase of 2.3 percentage points was due to a favorable sales mix.
Operating expenses: the year over year increase of $5.3 million was primarily due to adverse movements to the provisions for doubtful debts, together with increased operating expenses and increased employee-related costs, including higher provisions for performance-related remuneration accruals.
Other Income Statement Captions
Corporate costs: the year over year increase of $5.3 million was primarily due to higher legal and compliance expenses, together with higher information technology costs including additional amortization for our new ERP system, and higher provisions for performance-related remuneration accruals, being partly offset by lower legacy costs of closed operations and a favorable revaluation for our U.K. emissions trading scheme credits.
Adjustment to fair value of contingent consideration: is a credit in the current year of $4.6 million compared to an expense in the prior year of $1.5 million. The adjustment relates to the acquisition of QGP within our Performance Chemicals segment. The credit in the current year relates to a reduction in the expected payable, together with the lower accretion charge calculated on the lower expected payable. See Note 10 of the Notes to the Condensed Consolidated Financial Statements for additional information.
Other net income/(expense): for the six months ended June 30, 2026 was $3.7 million income compared to a $4.4 million expense in the three months ended June 30, 2025, primarily driven by the revaluation of foreign currency forward contracts, and the foreign currency translation of non-USD balances in the group.
Interest income/(expense), net: in the six months ended June 30, 2026 was $1.6 million of income compared to $5.1 million of income in the six months ended June 30, 2025, driven by lower interest rates and lower cash balances in the current year.
Income taxes: the effective tax rate was 23.9% and 25.8% in the first six months of 2026 and 2025, respectively. The adjusted effective tax rate, once adjusted for the items set out in the following table, was 23.0% in 2026 compared with 23.7% in 2025. The 0.7% decrease in the adjusted effective rate was primarily due to the fact that a higher proportion of the Company’s profits are being generated in lower tax jurisdictions. The Company believes that this adjusted effective tax rate, a non-GAAP financial measure, provides useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, management uses this non-GAAP financial measure internally to evaluate the performance of the Company’s operations and for planning and forecasting in subsequent periods.
In the threesix months ended MarchJune 31,30, 2026 our working capital increased by $19.8$12.1 million, while our adjusted working capital increased by $20.1$55.1 million. The difference is primarily due to the exclusion of the movements for cash and cash equivalents together withand the changesmovements for income taxes, being partly offset by the changeother movements shown in the valuetable of acquisition-related contingent consideration.below.
We had a $11.9$66.3 million increase in trade and other accounts receivable, including a $2.4$3.6 million increase in allowances, which was primarily due to increased sales for all our Fuel Specialties and Oilfield Services segments. Days’ sales outstanding decreased in our Performance Chemicals segment from 72 days to 66 days; increased from 57 days to 5962 days in our Fuel Specialties segment; and increased from 64 days to 6880 days in our Oilfield Services segment.
We had a $7.8$8.0 million decreaseincrease in inventories, including a $1.0$2.1 million decreaseincrease in allowances, which was primarily driven by lowerhigher levels of rawfinished materialsgoods infor our Performance Chemicals and Fuel Specialties segments.segment due to the timing of production. The Company continues to maintain inventory levels necessary to manage the risk of potential supply chain disruption for certain key raw materials, especially in our Fuel Specialties segment. Days’ sales in inventory in our Performance Chemicals segment decreased from 65 days to 5853 days; decreasedincreased from 184133 days to 132144 days in our Fuel Specialties segment; and decreased from 83 days to 6461 days in our Oilfield Services segment.
We had a $19.2$12.4 million decreaseincrease in accounts payable and accrued liabilities, which was dependent on the timing of payments for each of our reporting segments. Creditor days (including goods received not invoiced) have decreased in our Performance Chemicals segment from 50 days to 4749 days; decreased from 58 days to 5254 days in our Fuel Specialties segment; and increased from 46 days to 4759 days in our Oilfield Services segment. The changes for creditor days are impacted by the timing of sales and cost of sales in the quarter, when using a countback methodology.
We generated cash from operating activities of $17.6$24.8 million in the threesix months ended MarchJune 31,30, 2026 compared to $28.3$38.8 million in the threesix months ended MarchJune 31,30, 2025. The decrease in cash generated from operating activities compared to the prior year was primarily related to decreasedhigher operatingincreases incomein afterworking adjustingcapital, forbeing thepartly changesoffset to the fair value of contingent consideration, together withby the timing of income tax payments.
At MarchJune 31,30, 2026 and December 31, 2025, we had cash and cash equivalents of $289.1$250.2 million and $292.5 million, respectively, of which $120.6$131.4 million and $145.4 million, respectively, were held by non-U.S. subsidiaries principally in the United Kingdom.
The decrease in cash and cash equivalents of $3.4$42.3 million for the threesix months ended MarchJune 31,30, 2026 was primarily driven by our continued investments in capital projects, payments for our new ERP system implementationimplementation, payment of our semi-annual dividend and the repurchases of our common stock, being partly offset by the cash generated from operating activities.
At MarchJune 31,30, 2026, and December 31, 2025, we had no debt outstanding under the revolving credit facility and no obligations were outstanding under finance leases. See Note 8 of the Notes to the Condensed Consolidated Financial Statements for additional information.
IOSP insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding IOSP (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 568,709 | $46.3M | 0.03% | Reduced 4% |
| AQR Capital Management (Cliff Asness) | 2026-06-30 | 482,545 | $39.3M | 0.01% | Added 55% |
| Renaissance Technologies | 2026-06-30 | 185,000 | $15.1M | 0.02% | Added 56% |
| D. E. Shaw & Co. | 2026-06-30 | 165,746 | $13.5M | 0.01% | Reduced 42% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 98,549 | $8.0M | 0.0% | Reduced 55% |
| Millennium Management (Israel Englander) | 2026-06-30 | 61,427 | $4.5M | — | Sold out |
| Point72 Asset Management (Steve Cohen) | 2026-06-30 | 42,648 | $3.5M | 0.01% | Reduced 74% |
| Bridgewater Associates | 2026-06-30 | 5,950 | $434.5K | — | Sold out |
| Gotham Asset Management (Joel Greenblatt) | 2026-06-30 | 4,848 | $394.6K | 0.0% | Reduced 37% |